French gene therapy biotech gets €33M to follow Krystal's blueprint

Philippe Chambon, Cyllene Therapeutics CEO July 7, 2026 01:30 AM EDT FinancingStartupsCell/Gene Tx French gene ther­a­py biotech gets €33M to fol­low Krys­tal's blue­print Kyle LaHucik Biotech Correspondent A small French-US biotech has gath­ered more funds to see if it can fol­low in the foot­steps of Krys­tal Biotech in the HSV-based gene ther­a­py … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER